Hugh E. Stephenson Professor of Surgery (Surgical Oncology), School of Medicine
NextGen Focus Area: Cancer
Dr. Staveley-O’Carroll has a broad background in all phases of therapy development and implementation: leading multidisciplinary cancer-care teams, leading large National Cancer Institute and VA Grants with multiple investigators, and leading investigator-initiated clinical trials. His clinical expertise is focused on liver, pancreas, and foregut tumors, and his research and therapy-development activities center around enhancing the immune response to these tumors.
Precision Health Impact:
- Developing new cancer treatments
- Investigating immunotherapeutic, chemotherapeutic, and nanoparticle agents in a variety of cancers
Department website: https://www.muhealth.org/doctors/kevin-staveley-ocarroll-md